Study ID	Intervention(s) and comparator(s)	Participants included in analysis (N)	Deaths (N)	Deaths (%)	Participants with at least one adverse event (N)	Participants with at least one adverse event (%)	Participants with at least one severe/serious adverse event (N)	Participants with at least one severe/serious adverse event (%)
Timmers 2016 (cross‐over RCT)	I: trans‐resveratrol + oral hypoglycaemic agent(s) or diet alone	17	0	0	0	0	0	0
	C: placebo + oral hypoglycaemic agent(s) or diet alone	17	0	0	0	0	0	0
Thazhath 2016 (cross‐over RCT)	I: resveratrol	14	0	0	0	0	0	0
	C: placebo	14	0	0	0	0	0	0
Brasnyo 2011 (parallel RCT)	I: trans‐resveratrol	10	0	0	0	0	0	0
	C: placebo	9	0	0	0	0	0	0
— denotes not reported. C: comparator, I: intervention, N: number of participants.